NASDAQ
Citius Pharmaceuticals, Inc. (CTXR) has a fcf yield of -193.52% as of Friday, May 29, 2026. This represents a 1109.80% decrease compared to its 12-month average of -16.00%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.